Registered entities
De Novo Pharmaceuticals Limited
Reg. No. 3761178Germany
Investor mix
9 investors on record; lead investors include Merlin Biosciences.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 56% |
| Private equity | 2 | 22% |
| Other / undisclosed | 2 | 22% |
Provider of computational drug design software and services
9 investors on record; lead investors include Merlin Biosciences.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 56% |
| Private equity | 2 | 22% |
| Other / undisclosed | 2 | 22% |